市场调查报告书
商品编码
1510646
2030 年亚太地区医疗保健 CRM 市场预测 - 区域分析 - 按部署模式、产品类型、应用程式和最终用户Asia Pacific Healthcare CRM Market Forecast to 2030 - Regional Analysis - by Deployment Mode, Product Type, Application, and End User |
2022年亚太地区医疗保健CRM市场价值为11.6617亿美元,预计到2030年将达到27.455亿美元;预计2022年至2030年复合年增长率为11.3%。
物联网和人工智慧知识的增加推动亚太地区医疗保健 CRM 市场的发展
对数据驱动的洞察、分析和人口健康管理的需求正在极大地促进医疗保健产业的发展,进而推动对医疗保健 CRM 的需求。这种需求的增长可能与人们日益重视基于价值的护理以及医疗机构改善患者治疗结果、降低成本和提高整体护理品质的需求有关。数据驱动的洞察分析在医疗保健 CRM 中至关重要,因为它们允许组织检查和评估大量患者资料,以确定趋势、模式和相关性。这使得医疗保健从业者能够更好地了解患者群体,从而能够就治疗计划、干预措施和资源分配做出更准确的决策。医疗保健组织还可以透过采用数据驱动的分析来识别高风险患者、预测潜在疾病并主动干预以防止负面结果。同样,人口健康管理是亚太地区医疗保健 CRM 市场对数据驱动的洞察和分析需求不断增长的另一个重要驱动力。人口健康管理的重点是改善整个人口的健康结果,要求医疗机构对其患者群体以及影响其健康的因素有广泛的了解。数据驱动的洞察分析允许医疗保健专业人员根据人口统计、临床问题和风险因素等标准对患者群体进行细分。这使他们能够根据不同患者群体的个人需求提供个人化的医疗服务和治疗计划。
此外,医疗保健 CRM 开发人员快速将先进的分析和人口健康管理功能整合到医疗保健 CRM 平台中。这些功能使医疗保健组织能够使用资料来增强临床和营运结果,从而提供更好的患者护理并降低成本。因此,对数据驱动的洞察、分析和人口健康管理的需求不断增长,推动了对医疗保健 CRM 的需求,以改善患者治疗结果、降低成本并提高整体护理质量,从而推动亚太医疗保健 CRM 市场的成长。
亚太地区医疗保健 CRM 市场概览
由于医疗保健产业越来越多地采用数位技术,预计未来几年中国医疗保健 CRM 市场将显着成长。中国政府正在推广数位医疗解决方案,以提高医疗服务的品质和可近性。根据「健康中国2030」计划,中国计划在未来几年大力投资推动医疗技术创新。这笔支出旨在透过技术进步和医疗保健系统的改善来确保中国的健康公平。
此外,中国是世界上人口最稠密的国家之一。目前人口约14.1亿。根据2020年10月发布的全球疾病负担(GBD)研究,该国人口容易罹患传染病、慢性病和急性病。中国报告了中风、癌症、阿兹海默症和糖尿病等多种疾病的发生率。患者数量的增加以及对更好的医疗保健服务的需求不断增加,推动了中国亚太医疗保健 CRM 市场的成长。此外,根据未来健康指数的资料,94%的中国医疗保健专业人员使用数位健康技术或行动健康应用程式。本土主要企业的不断壮大正在推动中国医疗保健 CRM 市场的成长。製造商正致力于扩大其全球战略影响力和具有独特技术能力的专业知识,从而推动中国市场的成长。老龄化人口已成为医疗保健 CRM 软体需求增加的主要原因之一,因为他们由于身体压力而无法随时去医院,因此需要适当的就诊时间表和家庭护理环境的数位预约。 2019年,中国65岁以上人口占总人口的12.6%。人口老化的压力癌症、阿兹海默症和糖尿病等疾病的盛行率不断上升。因此,医院就诊和线上预约的需求将持续增长,这对中国的医疗保健 CRM 软体提出了新的要求。
亚太地区医疗保健 CRM 市场收入及 2030 年预测(百万美元)
亚太地区医疗保健 CRM 市场细分
亚太地区医疗保健 CRM 市场按部署模式、产品类型、应用程式、最终用户和国家/地区进行分类。
根据部署模式,亚太地区医疗保健 CRM 市场可分为基于云端的和本地的。 2022 年,基于云端的细分市场占据了更大的市场份额。
从产品类型来看,亚太地区医疗保健CRM市场分为营运型CRM、分析型CRM及协作型CRM。 2022 年,运营型 CRM 细分市场将占据更大的市场份额。
按应用划分,亚太地区医疗保健 CRM 市场分为关係管理、个案管理、个案协调、社区外展等。关係管理细分市场在2022年占据最大的市场份额。病例协调部分进一步细分为病患资讯管理和预授权/资格。社区外展部分是进一步的服务外展/推广和社区健康教育。
按最终用户划分,亚太地区医疗保健 CRM 市场分为提供者、付款人等。 2022 年,提供商细分市场占据最大的市场份额。
按国家/地区划分,亚太地区医疗保健 CRM 市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022 年,中国在亚太医疗保健 CRM 市场份额中占据主导地位。
International Business Machines Corp、IQVIA Holdings Inc、Microsoft Corp、Oracle Corp、Pegasystems Inc、Sage Group Plc、Salesforce Inc、SAP SE、SugarCRM Inc、Veeva Systems Inc 和 Zendesk Inc 是亚太地区医疗保健 CRM 领域的领先公司市场。
表中的内容
The Asia Pacific healthcare CRM market was valued at US$ 1,166.17 million in 2022 and is expected to reach US$ 2,745.50 million by 2030; it is estimated to register a CAGR of 11.3% from 2022 to 2030.
Increasing Knowledge About Internet of Things and Artificial Intelligence Boosts Asia Pacific Healthcare CRM Market
The demand for data-driven insights, analytics, and population health management is significantly promoting the development of the healthcare industry, which, in turn, propels the demand for healthcare CRM. This increase in demand can be related to the growing emphasis on value-based care and the demand for healthcare organizations to improve patient outcomes, lower costs, and improve overall care quality. Data-driven insights analytics are critical in healthcare CRM since they allow organizations to examine and evaluate large volumes of patient data to identify trends, patterns, and correlations. This enables healthcare practitioners to understand their patient population better, allowing them to make more accurate decisions about treatment plans, interventions, and resource allocation. Healthcare organizations may also identify high-risk patients, forecast prospective illnesses, and intervene proactively to prevent negative outcomes by employing data-driven analytics. Similarly, population health management is another significant driver of the growing demand for data-driven insights and analytics in the Asia Pacific healthcare CRM market. Population health management, focusing on improving the health outcomes of entire populations, necessitates healthcare organizations having an extensive understanding of their patient population and the factors that impact their health. Data-driven insights analytics allow healthcare professionals to segment their patient population based on criteria including demographics, clinical problems, and risk factors. This allows them to personalize medical services and treatment plans to the individual requirements of distinct patient groups.
Furthermore, healthcare CRM developers rapidly integrate advanced analytics and population health management capabilities into healthcare CRM platforms. These capabilities enable healthcare organizations to use data to enhance clinical and operational outcomes, resulting in better patient care and lower costs. Thus, the increasing demand for data-driven insights, analytics, and population health management propels the demand for healthcare CRM to improve patient outcomes, reduce costs, and enhance the overall quality of care, which fuels the growth of the Asia Pacific healthcare CRM market.
Asia Pacific Healthcare CRM Market Overview
The market for healthcare CRM in China is expected to witness significant growth in the coming years due to the increasing adoption of digital technologies in the healthcare sector. The Chinese government is promoting digital health solutions to improve the quality and accessibility of healthcare services. Under the Healthy China 2030 plan, China plans to invest significantly in advancing its healthcare technology innovation in the coming years. This expenditure is intended to ensure health equity within China through technological advancements and improvements to the healthcare system.
Additionally, China is among the most densely populated countries across the world. The current population is ~1.41 billion. According to the Global Burden of Disease (GBD) study published in October 2020, the population in the country is prone to infectious, chronic, and acute diseases. China reports the incidence of many diseases such as stroke, cancer, Alzheimer's, and diabetes. The rising number of patients and the increasing demand for better healthcare services boost the Asia Pacific healthcare CRM market growth in China. Furthermore, according to data from the Future Health Index, 94% of Chinese healthcare professionals used digital health technology or mobile health apps. The growing presence of local key players is boosting the China healthcare CRM market growth. Manufacturers are focusing on expanding their strategic global presence and specialized expertise with exclusive technological capabilities, leading to the market growth in China. Aging population has become one of the major contributors to the increased demand for healthcare CRM software as they are unable to visit the hospital anytime due to physical stress and thus require a proper schedule for medical visits and a digital appointment for home care settings. In 2019, 12.6% of China's population was over 65. Also, as per WHO, by 2040, ~402 million people (i.e., 28% of the total population) will be over 60. Thus, China is facing pressures of an aging population and constant rise in the prevalence of diseases such as cancer, Alzheimer's disease, and diabetes. As a result, demand for hospital visits and online appointments will continue to rise, setting new requirements for healthcare CRM software in China.
Asia Pacific Healthcare CRM Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Healthcare CRM Market Segmentation
The Asia Pacific healthcare CRM market is categorized into deployment mode, product type, application, and end user, and country.
Based on deployment mode, the Asia Pacific healthcare CRM market is bifurcated cloud based and on-premise. The cloud based segment held a larger market share in 2022.
In terms of product type, the Asia Pacific healthcare CRM market is categorized into operational CRM, analytical CRM, and collaborative CRM. The operational CRM segment held a larger market share in 2022.
By application, the Asia Pacific healthcare CRM market is segmented into relationship management, case management, case coordination, community outreach, and others. The relationship management segment held the largest market share in 2022. The case management segment is further subsegmented into disease management and clinical trials relationship management. The case coordination segment is further subsegmented into patient information management and pre-authorizations / eligibility. The community outreach segment is further services outreach/promotion and community health education.
By end user, the Asia Pacific healthcare CRM market is segmented into providers, payers, and others. The providers segment held the largest market share in 2022.
By country, the Asia Pacific healthcare CRM market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific healthcare CRM market share in 2022.
International Business Machines Corp, IQVIA Holdings Inc, Microsoft Corp, Oracle Corp, Pegasystems Inc, Sage Group Plc, Salesforce Inc, SAP SE, SugarCRM Inc, Veeva Systems Inc, and Zendesk Inc are among the leading companies operating in the Asia Pacific healthcare CRM market.
Table of Content